CXC13 - Overview: CXCL13 Immunostain, Technical Component Only
Assessment of CXCL13 (CXC motif chemokine ligand 13) expression
CEA - Overview: Carcinoembryonic Antigen (CEA), Serum
Monitoring colorectal cancer and selected other cancers such as medullary thyroid carcinoma May be useful in assessing the effectiveness of chemotherapy or radiation treatment This test is not useful for screening the general population...
CDOU - Overview: Cadmium Occupational Exposure, Random, Urine
Detecting occupational exposure to cadmium using random urine specimens
CHOU - Overview: Carbohydrate, Urine
Screening for conditions associated with increased excretion of fructose, galactose, and xylose This test is not recommended as a follow up test for abnormal newborn screening for galactosemia.
COKEM - Overview: Cocaine and Metabolites Confirmation, Meconium
Detecting in utero drug exposure up to 5 months before birth
CD15 - Overview: CD15 Immunostain, Technical Component Only
Phenotyping leukemias and lymphomas
CALNN - Overview: Calretinin Immunostain, Technical Component Only
Separating mesotheliomas from carcinomas which usually lack expression of calretinin
DULOX - Overview: Duloxetine, Serum
Monitoring duloxetine serum concentration during therapy Evaluating potential duloxetine toxicity Evaluating patient compliance
ETGS - Overview: Ethyl Glucuronide Screen, Random, Urine
Screening for drug abuse involving alcohol
HPL - Overview: Human Placental Lactogen Immunostain, Technical Component Only
Aids in the identification of placenta-related tumors
newborn_screen_follow-up_for_glucose-6-phosphate_dehydrogenase__g-6-pd__deficiency.pdf
Foundation for Medical Education and Research (MFMER). All rights reserved. 03/2024 Decreased glucose-6-phosphate dehydrogenase (G6PD) Not G6PD deficiency. In infants with hyperbilirubinemia, consider...
glucose-6-phosphate-dehydrogenase-deficiency-diagnostic-algorithm.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency Diagnostic Algorithm * If patient status is post-allogeneic stem...
Multi-Factor Authentication for Mayo Clinic Laboratories Applications User’s Guide Page 2 6/27/2024 Multi-Factor Authentication User’s Guide TABLE OF CONTENTS Introduction ....................
glucose-6-phosphate-dehydrogenase-genotyping-interpretive-algorithm.pdf
In the following situations, order G6PDZ / Glucose-6-Phosphate Dehydrogenase (G6PD) Full Gene Sequencing: ■ To determine carrier status (female patient) or affected status (male patient) ■ Previous...
04/2024© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Acute Tickborne Disease Testing Algorithm for Mayo Clinic Order: SFGP / Spotted Fever Group Antibody, IgG and IgM, Serum Empiric treatment...